Coeurative

Coeurative, Inc. is developing pharmaceutical strategies for the management of diseases associated with cellular hypoxia, including a novel class of coronary vasodilators for pharmaceutical use in the setting of symptoma

placeRoanoke, Virginia, United States calendar_todayFounded 2012 language coeurative.com

Social engagement

Social engagement: 347 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

13 Mar 2026
Product launch
CR-0305
Coming soon